This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Robert Meehan, M.D.
Senior Director of Clinical Development at Moderna Therapeutics


Dr. Robert Meehan is a board-certified physician in oncology and an experienced pharmaceutical executive with over 10 years of leadership experience in biotechnology and pharmaceutical development. He joined Moderna in 2017 to lead the company's efforts to develop mRNA-based medicines including individualized therapies for cancer patients. He was the clinical lead for the oncology portfolio as it entered into clinic and mRNA-4157 INT through the current developments including the Breakthrough and PRIME designations. He is experienced in basic, translational, and clinical tumor immunology and all aspects of drug development. Prior to joining Moderna, Dr. Meehan was a staff clinician at the National Cancer Institute in the DTC. He has authored many publications and is an inventor on multiple patents.

Agenda Sessions

  • mRNA-4157 Individualized Neoantigen Therapy: mRNA Therapeutics Coming of Age in Cancer